News 2025 - Forschungszentrum Borstel, Leibniz Lungenzentrum

14.02.2025

Borsteler Biologielaborantinnen und Biologielaboranten verabschiedet

Am 31.01 wurden im Gartensaal des Borsteler Herrenhauses insgesamt 12 Biologielaborantinnen und Biologielaboranten in die Berufswelt entlassen und erhielten im Rahmen der offiziellen Entlassungsfeier ihre Zeugnisse und Gesellenbriefe. Gemeinsam mit ihren Familien, den Ausbildern und den Kolleginnen und Kollegen feierten Sie ihre großartigen Leistungen.

12.02.2025

First Patient Randomized in the PARADIGM4TB Trial in Europe– Expanding Tuberculosis Research Across Continents

Clinical study to evaluate innovative tuberculosis treatment regimens is now being expanded following successful implementation in Africa.

11.02.2025

International Day of Women and Girls in Science

Today is International Day of Women and Girls in Science. Since 2015, this day has recognized the role that women and girls play in science and technology. Women are still underrepresented in science. We at Borstel are working to change this and are pleased that we have been able to fill more management positions with women in recent years. But there is still a long way to go!

04.02.2025

World Cancer Day 2025: Drug-Repurposing

Prof. Torsten Goldmann and his team from the “Histology” are investigating the TGF-beta signaling pathway in lung cancer as a new therapeutic target in a project funded by the German Centre for Lung Research (DZL).

03.02.2025

New RNA-based biomarker TB27 enables rapid monitoring of therapy response in tuberculosis

Borstel, 03.02.2025 – A team of researchers led by Dr. Maja Reimann at the Research Center Borstel, Leibniz Lung Center, has developed an RNA-based biomarker that can monitor treatment response in tuberculosis (TB) without bacterial culture.

Page 4 of 5